NCT05750875View on ClinicalTrials.gov

Gabapentin Versus Loratadine in Uremic Pruritus

PHASE4CompletedINTERVENTIONAL
Enrollment

64

Participants

Timeline

Start Date

May 1, 2022

Primary Completion Date

October 31, 2022

Study Completion Date

October 31, 2022

Conditions
PruritusUremiaChronic Kidney Diseases
Interventions
DRUG

Loratadine

Participants were given loratadine 10mg, oral, daily, for 4 weeks

DRUG

Gabapentin

Participants were given gabapentin 100mg, oral, daily, for 4 weeks

Trial Locations (1)

54000

King Edward Medical University/Mayo Hospital, Lahore

All Listed Sponsors
lead

King Edward Medical University

OTHER